Inhibition of immune activation by a novel nuclear factor-kappa B inhibitor in HTLV-I-associated neurologic disease. [electronic resource]
- Blood Mar 2011
- 3363-9 p. digital
Publication Type: Journal Article; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't
1528-0020
10.1182/blood-2010-10-306571 doi
Benzamides--pharmacology Cell Proliferation--drug effects Cells, Cultured Cyclohexanones--pharmacology Drug Evaluation, Preclinical HeLa Cells Human T-lymphotropic virus 1--drug effects Humans Immunologic Factors--pharmacology Immunotherapy--methods Leukocytes, Mononuclear--immunology Lymphocyte Activation--drug effects NF-kappa B--antagonists & inhibitors Paraparesis, Tropical Spastic--blood Signal Transduction--drug effects Viral Load--drug effects